Modifying the Non-Muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00175
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Mutational Landscape of Non-Muscle-Invasive Bladder Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2018English

Prediction Tools in Non-Muscle Invasive Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2019English

Histological Variants in Non-Muscle Invasive Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2019English

Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer

Bladder Cancer
OncologyUrology
2020English

Urine-Derived Lymphocytes as a Non-Invasive Measure of the Bladder Tumor Immune Microenvironment

Journal of Experimental Medicine
MedicineAllergyImmunology
2018English

Bacillus Calmette–Guérin‐unresponsive Non‐muscle‐invasive Bladder Cancer: Its Definition and Future Therapeutic Strategies

International Journal of Urology
Urology
2019English

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2011English

Serum microRNAs as Predictors of Risk for Non-Muscle Invasive Bladder Cancer

Oncotarget
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy